6 ms·
To be clear, this isn't saying that any anti-depressant is effective for COVID. It appears to be a unique side-effect of Fluvoxamine. There are several existin
by PragmaticPulp 6y ago
To be clear, this isn't saying that any anti-depressant is effective for COVID. It appears to be a unique side-effect of Fluvoxamine.
There are several existing drugs which have been found to have modulatory effects on early COVID infections. The key word here is "early", as most of them only have a significant impact before the infection gets out of control.
Keep in mind that Hydroxychloroquine is one of the existing drugs discovered to have some effect on early infections, but it clearly failed to have much impact on late-stage infections.
The study authors were careful to exclude severe or late-stage infections from their trial to avoid similar failures:
> Participants were community-living, nonhospitalized adults with confirmed severe acute respiratory syndrome coronavirus 2 infection, with COVID-19 symptom onset within 7 days and oxygen saturation of 92% or greater.
- mrfusion 6y agoIt would probably be any SSRI though?
- PragmaticPulp 6y agoNo, it's strictly Fluvoxamine as far as we know. SSRIs aren't all interchangeable, especially when it comes to side effects. Fluvoxamine is very different than other SSRIs because it has significant effects at the sigma-1 receptor. The only other SSRI with significant sigma-1 activity is Sertraline, but it has the opposite effect at sigma-1. However, it's possible that the anti-COVID properties are unrelated to Fluvoxamine's actions at the serotonin transporter or the sigma-1 receptor. We just don't know.
- mrandish 6y agoThe similarly named Fluoxetine has lesser (but still significant) effects at Sigma-1. Since Fluoxetine is so widely distributed (because it's Prozac), there is quite a bit of observational data that Fluoxetine is also correlated with reduced clinical severity. Obviously, even a strong correlation is not causation but it is certainly grounds for prioritizing investigation, especially since Fluoxetine/Prozac is very well-tolerated, inexpensive and widely available in mass quantity.
- PragmaticPulp 6y agoFluvoxamine has the highest sigma-1 affinity by far. Fluoxetine's affinity is about an order of magnitude lower. We don't even know if sigma-1 is responsible for the effects observed, but it wouldn't make sense to give someone Fluoxetine instead of Fluvoxamine (which is also widely available), especially when it would require overdose levels of Fluoxetine to achieve similar sigma-1 effects. More numbers available in the full text here: https://pubmed.ncbi.nlm.nih.gov/24508523/ https://pubmed.ncbi.nlm.nih.gov/24508523/
- WalterSear 6y agoIt's suspected to be a specific side effect, not a part of the reuptake inhibition.
- xkcd-sucks 6y agoGenerally speaking, "SSRI" is an ideal goal which isn't perfectly realized; all drugs in that class bind "off-target" to proteins other than SERT. In this case, fluvoxamine pharmacology is pretty clean and there is experimental evidence only for binding to sigma-1 receptor in addition to SERT (also to a whole bunch of CYP enzymes). Unfortunately the function of sigma-1 is not well understood but it affects calcium signalling in intracellular compartments where covid-19 replicates
- Herodotus38 6y ago“ Keep in mind that Hydroxychloroquine is one of the existing drugs discovered to have some effect on early infections, but it clearly failed to have much impact on late-stage infections” Do you mind sharing your evidence that HCQ helps with early infections? Because I know many studies that showed no benefit, for example: https://www.nejm.org/doi/full/10.1056/nejmoa2016638 https://www.nejm.org/doi/full/10.1056/nejmoa2016638 That is one of many studies.
- YetAnotherNick 6y agoBreakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies: https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_2020.01047/_pdf/-char/en https://www.jstage.jst.go.jp/article/bst/advpub/0/advpub_202...
- Herodotus38 6y agoThat appears (there is no date) to be a brief paper from February or March. I’m interested in what you think that paper says? Read what the title says and read the short paper. It has zero references to results of use in patients other than referring to a news release. There is link that it is being used in clinical trials, but no results. We know HCQ does not do anything for Covid after hundreds of studies. It is time to move on. Focus on other potential treatments.
- BlueTemplar 6y agoThere's a bunch of very professional-looking websites claiming the effectiveness of HCQ, especially early on : https://hcqtrial.com/ https://hcqtrial.com/ https://hcqmeta.com/ https://hcqmeta.com/ (And now https://c19study.com/ https://c19study.com/ ?) Sadly, I only have been able to find this as criticism : https://sciencebasedmedicine.org/hcqtrial-com-astroturf-and-disinformation-about-hydroxychloroquine-and-covid-19-on-steroids/ https://sciencebasedmedicine.org/hcqtrial-com-astroturf-and-...
- Herodotus38 6y ago
- loceng 6y agoIt makes me wonder - or seems to insinuate to - that Fluvoxamine may directly impact the immune system. The only other alternative is that some molecular structure of Fluvoxamine kills off the virus?